Loading...

FITC anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1.5_FITC_102110
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
  • GK1.5_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) FITC (filled histogram) or rat IgG2b, κ FITC isotype control (open histogram).
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100405 50 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100406 500 µg 80€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  2. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  3. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  4. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  5. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  6. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  7. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  8. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  9. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  10. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  11. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  12. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  13. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  14. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  15. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  16. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  17. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  18. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  19. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  20. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  21. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  22. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  23. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  24. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  25. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  26. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  27. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  28. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  29. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  30. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  31. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  32. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  33. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  34. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  35. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  36. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  37. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  38. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  39. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  40. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  41. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  42. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  43. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  44. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  45. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  46. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  47. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  48. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  49. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  50. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  51. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  52. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  53. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  54. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  55. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  56. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  57. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  58. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  59. White C, et al. 2014. J Immunol. 193:5933. PubMed
  60. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  61. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  62. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  63. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  64. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  65. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  66. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  67. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  68. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  69. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  70. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  71. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  72. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  73. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  74. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  75. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  76. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  77. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  78. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  79. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  80. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  81. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  82. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  83. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  84. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  85. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  86. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  87. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  88. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  89. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  90. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  91. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  92. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  93. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  94. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  95. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  96. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  97. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  98. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  99. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  100. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  101. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  102. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  103. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  104. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  105. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  106. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  107. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  108. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  109. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  110. Zeng A, et al. 2020. Oncol Rep. . PubMed
  111. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  112. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  113. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  114. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  115. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  116. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
  117. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  118. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  119. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  122. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  123. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  124. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  125. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  126. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  127. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  128. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  129. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  130. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  131. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  132. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  133. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  134. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  135. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  136. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  137. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  138. Li J, et al. 2020. Development. :. PubMed
  139. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  140. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  141. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  142. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  143. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  144. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  145. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  146. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  147. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  148. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  149. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  150. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  151. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  152. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  153. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  154. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  155. Lang V, et al. 2021. Elife. 10:. PubMed
  156. Ma K, et al. 2022. iScience. 25:104347. PubMed
  157. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  158. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  159. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  160. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  161. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  162. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  163. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  164. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  165. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  166. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  167. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  168. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  169. He R, et al. 2021. J Immunol. 206:2353. PubMed
  170. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  171. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  172. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  173. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  174. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  175. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  176. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  177. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  178. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  179. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  180. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  181. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  182. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  183. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  184. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  185. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  186. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  187. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  188. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  189. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  190. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  191. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  192. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  193. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  194. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  196. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  197. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  198. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  199. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  200. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  201. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  202. He X, et al. 2021. Small. 17:e2007165. PubMed
  203. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  204. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  205. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  206. Gawish R, et al. 2022. Elife. 11:. PubMed
  207. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  208. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  209. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  210. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  211. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  212. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  213. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  214. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  215. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  216. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  217. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  218. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  219. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  220. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  221. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  222. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  223. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  224. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  225. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  226. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  227. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  228. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  229. Toomer G, et al. 2022. Viruses. 14:. PubMed
  230. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  231. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  232. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  233. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  234. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  235. Mi Z, et al. 2021. Vaccines (Basel). 10: . PubMed
  236. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  237. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  238. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  239. Balood M, et al. 2022. Nature. 611:405. PubMed
  240. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  241. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  242. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  243. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  244. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  245. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  246. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  247. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  248. Sun Y, et al. 2023. Cell Mol Life Sci. 80:63. PubMed
  249. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  250. Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed
  251. Zander R, et al. 2022. Immunity. 55:475. PubMed
  252. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  253. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  254. Hamdi L, et al. 2022. Ann Clin Transl Neurol. 9:1792. PubMed
  255. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  256. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  257. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  258. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  259. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  260. Mackin S, et al. 2023. Nat Microbiol. 8:569. PubMed
  261. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  262. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  263. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  264. Fiedler T, et al. 2023. J Neuroinflammation. 20:100. PubMed
  265. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  266. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  267. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  268. Peymanfar Y, et al. 2023. Int J Mol Sci. 24:. PubMed
  269. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  270. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  271. Iwanami N, et al. 2023. Nat Commun. 14:3645. PubMed
  272. Solvay M, et al. 2023. J Immunother Cancer. 11:. PubMed
  273. Wang Z, et al. 2023. Sci Adv. 9:eabo4100. PubMed
RRID
AB_312690 (BioLegend Cat. No. 100405)
AB_312691 (BioLegend Cat. No. 100406)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
Go To Top Version: 1    Revision Date: 11.30.2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account